I believe many of us here saw this good, but short
Post# of 148167
(Total Views: 638)
Posted On: 04/29/2020 12:12:40 PM
I believe many of us here saw this good, but short and simple, article out yesterday following Monday's shareholder conference call:
https://www.clinicaltrialsarena.com/news/cyto...d-19-data/
It summarized and highlighted several things, especially to newcomers but more could have been dedicated to a most important new discovery Dr. Patterson announced:
COVID-19 IS A RANTES DISEASE = CCL5
As a layman (non-medical), I see this as a very important new finding indicating not only would Leronlimab be the safe and effective drug for HIV, 22 cancers and other ailments CytoDyn has indicated... but anything to do with renal/kidney function. Dr. Patterson is apparently the first in the WORLD to report through Leronlimab they would be able to quantify the virus in the plasma... which would help restore the immune system and decrease the viral factor in patients. He cautioned a need to be concerned about the blood supply... specifically the coronavirus being not only in the lungs but also in the blood itself.
In speaking with a cousin who is a surgeon, upon first telling him about our Leronlimab several weeks ago, he was excited about its potential to deal with Sepsis:
https://zaggocare.org/why-sepsis-dangerous/?g...e0EALw_wcB
Imagine all of that in one drug: Leronlimab (Vyrologix)
When the world learns about Leronlimab ... which has already taken COVID-19 patients (with liver transplants or heart-lung issues) off ventilators when other drugs could not help them... many might say thank God for the science and brilliant minds behind this "miracle" drug!
https://www.clinicaltrialsarena.com/news/cyto...d-19-data/
It summarized and highlighted several things, especially to newcomers but more could have been dedicated to a most important new discovery Dr. Patterson announced:
COVID-19 IS A RANTES DISEASE = CCL5
Quote:
RANTES is of broad clinical importance in an array of human diseases including AIDS, cancer, atherosclerosis, asthma, transplantation, and autoimmune diseases such as arthritis, diabetes and glomerulonephritis;6 Box 1 lists a variety of renal diseases in which expression of RANTES is involved.
As a layman (non-medical), I see this as a very important new finding indicating not only would Leronlimab be the safe and effective drug for HIV, 22 cancers and other ailments CytoDyn has indicated... but anything to do with renal/kidney function. Dr. Patterson is apparently the first in the WORLD to report through Leronlimab they would be able to quantify the virus in the plasma... which would help restore the immune system and decrease the viral factor in patients. He cautioned a need to be concerned about the blood supply... specifically the coronavirus being not only in the lungs but also in the blood itself.
In speaking with a cousin who is a surgeon, upon first telling him about our Leronlimab several weeks ago, he was excited about its potential to deal with Sepsis:
https://zaggocare.org/why-sepsis-dangerous/?g...e0EALw_wcB
Imagine all of that in one drug: Leronlimab (Vyrologix)
When the world learns about Leronlimab ... which has already taken COVID-19 patients (with liver transplants or heart-lung issues) off ventilators when other drugs could not help them... many might say thank God for the science and brilliant minds behind this "miracle" drug!
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼